Immunovant
Developing imeroprubart across six IgG-driven autoimmune diseases.
$40.58
After-hours close−0.61 (−1.48%)
At close$41.19(−6.00%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.73 | — | — |
| Aug 2026 | −$0.63 | −$0.75 | −19.3% |
| May 2026 | −$0.60 | −$0.73 | −21.7% |
| Feb 2026 | −$0.72 | −$0.61 | +15.3% |
| Nov 2025 | −$0.72 | −$0.73 | −1.4% |
The latest year is open to everyone — the 29 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.73 | — | — | $7.1M | — | — |
| Aug 6, 2026 | −$0.63 | −$0.75 | −19.3% | $7.1M | $7.1M | 0.0% |
| May 20, 2026 | −$0.60 | −$0.73 | −21.7% | — | — | — |
| Feb 6, 2026 | −$0.72 | −$0.61 | +15.3% | $6.0M | — | — |
| Nov 10, 2025 | −$0.72 | −$0.73 | −1.4% | — | — | — |
The latest year is open to everyone — the 29 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 29, 2025 | ||||||
| Feb 6, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 29, 2024 | ||||||
| Feb 12, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 22, 2023 | ||||||
| Feb 3, 2023 | ||||||
| Nov 4, 2022 | ||||||
| Aug 5, 2022 | ||||||
| Jun 8, 2022 | ||||||
| Feb 4, 2022 | ||||||
| Nov 5, 2021 | ||||||
| Aug 9, 2021 | ||||||
| Jun 1, 2021 | ||||||
| Feb 16, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 12, 2020 | ||||||
| Jun 29, 2020 | ||||||
| Feb 14, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 12, 2019 | ||||||
| Jun 12, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||